Status:
COMPLETED
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Schizophrenia affects 2.4 million Americans and causes significant individual and societal costs. Cognitive deficits including poor working memory arise early in the course of illness, account for poo...
Detailed Description
Schizophrenia (SCZ) is a chronic debilitating mental disorder that affects 2.4 million Americans and leads to considerable individual and societal costs. In patients with SCZ, cognitive deficits (CD) ...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia/schizoaffective disorder
Exclusion
- Active substance use disorders in the last 30 days
- Medication changes in the last 30 days
- History of traumatic brain injury
- seizure disorder
- pregnancy
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03260257
Start Date
March 1 2018
End Date
April 1 2024
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California at San Diego
La Jolla, California, United States, 92093